Cargando…

Chemotherapy plus targeted drugs in conversion therapy for potentially resectable colorectal liver metastases: a meta-analysis

OBJECTIVES: To evaluate the safety and efficiency of the conversion therapy : chemotherapy plus anti-epidermal growth factor Receptor (EGFR) or anti-vascular endothelial growth factor receptor (VEGFR) monoclonal antibodies (MoAbs) with different rat sarcoma (RAS) status in patients with potentially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lu, Sun, Yinan, Zhao, Ben, Zhang, Huixian, Yu, Qianqian, Yuan, Xianglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342449/ https://www.ncbi.nlm.nih.gov/pubmed/27248177 http://dx.doi.org/10.18632/oncotarget.9675

Ejemplares similares

The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis
por: Liu, Wei, et al.
Publicado: (2016)

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing
por: Welsh, F K S, et al.
Publicado: (2007)

A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases
por: Sebagh, M, et al.
Publicado: (2014)

Resection of colorectal liver metastases following neoadjuvant chemotherapy
por: Chiappa, A, et al.
Publicado: (2007)

Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases
por: Satake, Hironaga, et al.
Publicado: (2021)

Systematic Review With Network Meta-Analysis: Adjuvant Chemotherapy for Resected Colorectal Liver Metastases
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
por: Garufi, C, et al.
Publicado: (2010)

Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
por: Zhu, Dexiang, et al.
Publicado: (2014)

Neoadjuvant chemotherapy (NCT) plus targeted agents versus NCT alone in colorectal liver metastases patients: A systematic review and meta-analysis
por: Cui, Chun-Hui, et al.
Publicado: (2015)

Efficacy of laparoscopic liver resection in colorectal liver metastases and the influence of preoperative chemotherapy
por: Kubota, Yoshihisa, et al.
Publicado: (2014)

The Role of Preoperative Chemotherapy in the Management of Synchronous Resectable Colorectal Liver Metastases: A Meta-Analysis
por: Tepelenis, Kostas, et al.
Publicado: (2023)

Initial Experiences of Simultaneous Laparoscopic Resection of Colorectal Cancer and Liver Metastases
por: Hoekstra, L. T., et al.
Publicado: (2012)

Influence of the Type and Amount of Liver Resection on the Survival of the Patients with Colorectal Metastases
por: Petrovski, Stefan, et al.
Publicado: (2018)

Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases
por: Barone, C, et al.
Publicado: (2007)

Neoadjuvant chemotherapy for patients with resectable colorectal cancer liver metastases: A systematic review and meta-analysis
por: Zhang, Yue, et al.
Publicado: (2021)

Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy?
por: Son, Sang-Yong, et al.
Publicado: (2011)

Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
por: Ichida, Hirofumi, et al.
Publicado: (2019)

Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases
por: Allard, M.‐A., et al.
Publicado: (2019)

A Reappraisal of Chemotherapy-Induced Liver Injury in Colorectal Liver Metastases before the Era of Antiangiogenics
por: Nguyen-Khac, Eric, et al.
Publicado: (2013)

Liver resection for non-colorectal metastases
por: Schwarz, Christoph, et al.
Publicado: (2018)

Meta-analysis of laparoscopic versus open liver resection for colorectal liver metastases
por: Tian, Zhi-qiang, et al.
Publicado: (2016)

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
por: Bertolini, F, et al.
Publicado: (2011)

BRAF V600E potentially determines “Oncological Resectability” for “Technically Resectable” colorectal liver metastases
por: Kobayashi, Shin, et al.
Publicado: (2021)

Radiofrequency ablation versus traditional liver resection and chemotherapy for liver metastases from gastric cancer
por: Tang, Kezhong, et al.
Publicado: (2020)

C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases
por: Wong, V K H, et al.
Publicado: (2007)

Multiple Laparoscopic Liver Resection for Colorectal Liver Metastases
por: Nassar, Alexandra, et al.
Publicado: (2023)

Liver transplantation for non-resectable colorectal liver metastases
por: Aziz, Hassan, et al.
Publicado: (2023)

Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy
por: Buisman, Florian E., et al.
Publicado: (2020)

A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
por: Bendell, Johanna C., et al.
Publicado: (2016)

Prophylactical Low Dose Whole-Liver Irradiation Inhibited Colorectal Liver Metastasis by Regulating Hepatic Niche in Mice
por: Wang, Lu, et al.
Publicado: (2020)

Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy
por: Ayez, Ninos, et al.
Publicado: (2011)

Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival
por: Homayounfar, K., et al.
Publicado: (2013)

Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases
por: Buisman, Florian E., et al.
Publicado: (2020)

Efficacy of neoadjuvant chemotherapy for initially resectable colorectal liver metastases: A retrospective cohort study
por: Takeda, Kazuhisa, et al.
Publicado: (2022)

Conversion to resectability using transcatheter arterial chemoembolization alternating with mFOLFOX6 in patients with colorectal liver metastases
por: Wang, Shuai, et al.
Publicado: (2019)

Resection after preoperative chemotherapy versus synchronous liver resection of colorectal cancer liver metastases: A propensity score matching analysis
por: Kim, Chan W., et al.
Publicado: (2017)

Postoperative chemotherapy with single-agent fluoropyrimidines after resection of colorectal cancer liver metastases: a meta-analysis of randomised trials
por: Mauri, Davide, et al.
Publicado: (2018)

Chemotherapy Plus Cetuximab versus Chemotherapy Alone for Patients with KRAS Wild Type Unresectable Liver-Confined Metastases Colorectal Cancer: An Updated Meta-Analysis of RCTs
por: Lv, W., et al.
Publicado: (2017)

Liver Resection in Patients With Synchronous Colorectal Liver and Lung Metastases
por: Horner, Allison, et al.
Publicado: (2016)

Hepatectomy versus Chemotherapy for Resectable Colorectal Liver Metastases in Progression after Perioperative Chemotherapy: Expanding the Boundaries of the Curative Intent
por: Famularo, Simone, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qebsnbaoc9g95rk2hr30v488k2